The board of directors at Prime Therapeutics LLC has named Jim DuCharme president and CEO, with him starting in that capacity Monday.
“Prime’s board of directors unanimously selected Jim to lead Prime into its next stage of growth and success,” Board Chairman Andrew Corbin, CEO and president of Blue Cross and Blue Shield of Kansas, said. “In his time at Prime, Jim has continually demonstrated the value of his experience, expertise and vision for Prime’s future.”
DuCharme joined Prime in 2012 as chief financial officer. He succeeds Eric Elliott, who in October announced his departure from Prime to pursue other opportunities.
While chief financial officer, DuCharme played an important role in prioritizing strategic investments that supported Prime's growth. In 2014, Prime’s membership grew to 26 million members — up from 6 million members in 2012.
“Prime is a great company with a strong culture rooted in delivering excellent service with a passion to help our members,” DuCharme said. “We will continue to grow by attracting new clients and owners, winning in the individual health insurance marketplace and building Prime Specialty Pharmacy into a top-three competitor.”
Before joining Prime, DuCharme served as chief financial officer and treasurer for Harvard Pilgrim Health Care, Capital District Physicians' Health Plan, and Blue Cross and Blue Shield of Vermont.
Alerts Sign-up